Table 1 Baseline characteristics between patients with and without SAP

Demographic

 Age, years, mean ± SD

66.99 ± 12.76

64.81 ± 12.70

72.75 ± 11.10

<0.001

 Sex, male, n(%)

180(69.8%)

127(67.9%)

53(74.6%)

0.293

Medical history

 Smoking, n(%)

56(21.7%)

41(21.9%)

15(21.1%)

0.890

 Alcohol drinking, n(%)

64(24.8%)

44(23.5%)

20(28.2%)

0.441

 Diabetes, n(%)

52(20.2%)

39(20.9%)

13(18.3%)

0.649

 Hypertension, n(%)

212(82.2%)

154(82.4%)

58(81.7%)

0.901

 Hyperlipidemia, n(%)

112(43.4%)

91(48.7%)

21(29.6%)

0.006

 Antiplatelet medication, n(%)

31(12.0%)

24(12.8%)

7(9.9%)

0.512

 Anticoagulant medication, n(%)

8(3.1%)

4(2.1%)

4(5.6%)

0.148

 Statin medication, n(%)

30(11.6%)

23(12.3%)

7(9.9%)

0.585

Clinical features

 SBP, mmHg, mean ± SD

156.14 ± 19.51

154.80 ± 19.99

159.89 ± 17.69

0.071

 DBP, mmHg, mean ± SD

89.52 ± 13.28

89.49 ± 12.88

89.60 ± 14.46

0.954

 NIHSS, median(IQR)

6(3–13)

5(2–9)

14(6–25)

<0.001

 Hematoma volume, ml, median(IQR)

6.55(2.85–14.11)

5.89(2.68–12.42)

8.83(4.44–18.74)

<0.001

Laboratory examination

 FBG, mmol/L, median(IQR)

5.57(5.05–6.76)

5.54(5.04–6.60)

5.82(5.09–6.92)

0.279

 TC, mmol/L, median(IQR)

4.34(3.85–4.87)

4.36(3.88–4.95)

4.34(3.70–4.78)

0.238

 TG, mmol/L, median(IQR)

1.31(0.94–1.93)

1.44(1.03–2.13)

1.19(0.70–1.56)

<0.001

 HDL-C, mmol/L, median(IQR)

1.22(1.07–1.44)

1.19(1.04–1.40)

1.33(1.12–1.60)

0.002

 LDL-C, mmol/L, mean ± SD

2.74 ± 0.94

2.81 ± 0.98

2.53 ± 0.78

0.029

 TG/HDL-C, median(IQR)

1.07(0.72–1.71)

1.27(0.81–1.94)

0.84(0.46–1.13)

<0.001